News | February 22, 2007

Ten Worst States for Heart Disease

Feb. 23, 2007 — West Virginia holds the dubious rank of the state with the highest percentage of residents with heart disease (10.4 percent), according to a study released this month by the Centers for Disease Control and Prevention. The lowest ranking state on the survey is Colorado.

Variations in lifestyle risk factors for heart disease vary state to state, the report suggested, which may account for the geographic disparities in the number of heart attacks and the incidence of heart disease.

“Different regions have different dietary patterns, different acceptable activities for exercise and differences in the availability of safe, easily accessible places to go for physical activity,” said Jonathan Neyer, epidemiologist in the CDC’s division for heart disease and stroke prevention, who spearheaded the study.

He also said that state and metropolitan policies that regulate smoking in restaurants, healthy food in schools and heart health education also make a difference.

The 10 states with the worst heart disease occurrences are:
1) West Virginia (10.4 percent)
2) Kentucky (8.8 percent)
3) Mississippi (8.0 percent)
4) Louisiana (7.9 percent)
5) Tennessee (7.6 percent)
6) Oklahoma (7.5 percent)
7) Alabama (7.4)
8) Florida (7.4 percent)
9) Missouri (7.3 percent)
10) Arizona (7.0 percent)

The study found these states comprise a high proportion of residents with multiple heart disease risk factors and a disproportionately high number of heart disease deaths. The same was found among residents living in Puerto Rico.

In examining the prevalence of heart disease, Neyer and his colleagues also looked at differences in race, gender and education. American Indians, for example, were found to be twice as likely to experience heart disease as Asian Americans. And a high school dropout is nearly twice as likely to have heart disease as a college graduate.

Besides Colorado, other states reporting lowest percentages of heart disease included: Nebraska, Wisconsin, Wyoming, New Mexico, Montana, Minnesota, Utah, Hawaii, as well as the District of Columbia and the U.S. Virgin Islands.

The study, titled “Prevalence of Heart Disease – United States, 2005,” was published in the Feb. 15 edition of “Morbidity and Mortality Weekly Report.” The study is based on an analysis of state-specific data collected from the Behavioral Risk Factor Surveillance System — a random phone survey of U.S. adults age 18 and older conducted by state/territorial health departments.

For more information visit

Related Content

Medtronic Receives FDA Approval for Less-Invasive Heart Pump Implant Procedure
Technology | Ventricular Assist Devices (VAD) | July 17, 2018
Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for a less-invasive implant approach...
CorWave's Next-generation Neptune LVAD Receives Funding

Image courtesy of CorWave

News | Ventricular Assist Devices (VAD) | July 11, 2018
French-based CorWave announced that its CALYPSO program has received 14 million euros to develop CorWave Neptune, a new...
Abbott Recalls the HeartMate 3 Left Ventricular Assist System, LVAD
News | Ventricular Assist Devices (VAD) | May 23, 2018
Abbott has initiated a Class I recall of the HeartMate 3 Left Ventricular Assist System due to a malfunction in the...
FDA Approves Abiomed Impella CP With SmartAssist and Optical Sensor
Technology | Ventricular Assist Devices (VAD) | April 02, 2018
Abiomed Inc. announced that it received U.S. Food and Drug Administration (FDA) Pre-Market Approval (PMA) for its...
Reduced Device Clotting, Decreased Strokes Seen With HeartMate 3 at Two Years
News | Ventricular Assist Devices (VAD) | March 13, 2018
At two years of follow-up, severely ill patients with advanced heart failure who received a novel heart pump fully...
Medtronic HeartWare HVAD System Approved for Destination Therapy
Technology | Ventricular Assist Devices (VAD) | October 04, 2017
October 4, 2017 — Medtronic received U.S.
Abiomed Receives FDA PMA Approval for Impella RP for Right Heart Failure
Technology | Ventricular Assist Devices (VAD) | September 28, 2017
Abiomed Inc. recently received U.S. Food and Drug Administration (FDA) pre-market approval (PMA) for the Impella RP ...
Abbott Receives FDA Approval for HeartMate 3 Left Ventricular Assist System
Technology | Ventricular Assist Devices (VAD) | August 29, 2017
Abbott announced it has received U.S. Food and Drug Administration (FDA) approval for its Full MagLev HeartMate 3 Left...
Pre-PCI Impella 2.5 Insertion Improves Survival in Left Main Coronary Artery Heart Attacks
News | Ventricular Assist Devices (VAD) | June 30, 2017
Abiomed Inc. announced the recent publication of a peer-reviewed retrospective study on hemodynamic support with the...
Overlay Init